Tak Paul Peter (CIK 1873905) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-06-26). Recent activity: Buy CADL (42,826 shares), Sell CADL (25,772 shares), Sell CADL (400 shares), Sell CADL (21,704 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-06-26 | Candel Therapeutics, Inc. (CADL) | Chief Executive Officer | Buy | 42,826 | $199,997 |
| 2025-03-20 | Candel Therapeutics, Inc. (CADL) | Chief Executive Officer | Sell | 25,772 | $226,020 |
| 2025-03-20 | Candel Therapeutics, Inc. (CADL) | Chief Executive Officer | Sell | 400 | $3,600 |
| 2025-01-17 | Candel Therapeutics, Inc. (CADL) | Chief Executive Officer | Sell | 21,704 | $156,920 |
Source: SEC Form 4 filings · as of 2025-06-26